首页> 美国卫生研究院文献>World Journal of Gastroenterology >Staging colorectal cancer with the TNM 7th: The presumption of innocence when applying the M category
【2h】

Staging colorectal cancer with the TNM 7th: The presumption of innocence when applying the M category

机译:TNM第7期分析结直肠癌:应用M类药物时无罪推定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One of the main changes of the current TNM-7 is the elimination of the category MX, since it has been a source of ambiguity and misinterpretation, especially by pathologists. Therefore the ultimate staging would be better performed by the patient’s clinician who can classify the disease M0 (no distant metastasis) or M1 (presence of distant metastasis), having access to the completeness of data resulting from clinical examination, imaging workup and pathology report. However this important change doesn’t take into account the diagnostic value and the challenge of small indeterminate visceral lesions encountered, in particular, during radiological staging of patients with colorectal cancer. In this article the diagnosis of these lesions with multiple imaging modalities, their frequency, significance and relevance to staging and disease management are described in a multidisciplinary way. In particular the interplay between clinical, radiological and pathological staging, which are usually conducted independently, is discussed. The integrated approach shows that there are both advantages and disadvantages to abandoning the MX category. To avoid ambiguity arising both by applying and interpreting MX category for stage assigning, its abandoning seems reasonable. The recognition of the importance of small lesion characterization raises the need for applying a separate category; therefore a proposal for their categorization is put forward. By using the proposed categorization the lack of consideration for indeterminate visceral lesions with the current staging system will be overcome, also optimizing tailored follow-up.
机译:当前的TNM-7的主要变化之一是取消了MX类,因为它一直是歧义和误解的来源,尤其是病理学家。因此,患者的临床医师可以更好地进行最终分期,他们可以将疾病分类为M0(无远处转移)或M1(有远处转移),并且可以获取由临床检查,影像学检查和病理报告得出的数据的完整性。但是,这一重要变化并未考虑到诊断价值以及特别是在结肠直肠癌患者的放射分期过程中遇到的不确定的内脏小病变的挑战。在本文中,以多学科的方式描述了利用多种成像方式对这些病变的诊断,其频率,重要性以及与分期和疾病管理的相关性。特别地,讨论了通常独立进行的临床,放射学和病理学分期之间的相互作用。综合方法表明,放弃MX类别既有优点也有缺点。为了避免通过为舞台分配应用和解释MX类别而引起歧义,放弃它似乎是合理的。认识到小病变特征的重要性,因此需要使用单独的类别。因此,提出了对其分类的建议。通过使用建议的分类,可以克服当前分期系统对不确定的内脏病变的考虑,从而优化定制的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号